Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer

Wojciech A. Cieślikowski, Joanna Budna-Tukan, Monika Świerczewska, Agnieszka Ida, Michał Hrab, Agnieszka Jankowiak, Martine Mazel, Michał Nowicki, Piotr Milecki, Klaus Pantel, Catherine Alix-Panabières, Maciej Zabel, Andrzej Antczak

Open source

DOI
10.3390/cancers12010160
Published
2020-01-09
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers12010160,
  title = {Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer},
  author = {Wojciech A. Cieślikowski and Joanna Budna-Tukan and Monika Świerczewska and Agnieszka Ida and Michał Hrab and Agnieszka Jankowiak and Martine Mazel and Michał Nowicki and Piotr Milecki and Klaus Pantel and Catherine Alix-Panabières and Maciej Zabel and Andrzej Antczak},
  year = {2020},
  journal = {Cancers},
  doi = {10.3390/cancers12010160},
  url = {https://doi.org/10.3390/cancers12010160}
}

RIS

TY  - JOUR
TI  - Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
AU  - Wojciech A. Cieślikowski
AU  - Joanna Budna-Tukan
AU  - Monika Świerczewska
AU  - Agnieszka Ida
AU  - Michał Hrab
AU  - Agnieszka Jankowiak
AU  - Martine Mazel
AU  - Michał Nowicki
AU  - Piotr Milecki
AU  - Klaus Pantel
AU  - Catherine Alix-Panabières
AU  - Maciej Zabel
AU  - Andrzej Antczak
PY  - 2020
JO  - Cancers
DO  - 10.3390/cancers12010160
UR  - https://doi.org/10.3390/cancers12010160
ER  - 

APA

Cieślikowski, W. A., Budna-Tukan, J., Świerczewska, M., Ida, A., Hrab, M., Jankowiak, A., Mazel, M., Nowicki, M., Milecki, P., Pantel, K., Alix-Panabières, C., Zabel, M., & Antczak, A. (2020). Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer. Cancers. https://doi.org/10.3390/cancers12010160

Source records